The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Open accessAbstract
Cultured mononuclear peripheral blood leukocytes (PBL) from nonimmune human beings and monkeys are nonpermissive to dengue 2 virus (D2V) infection at multiplicities of infection of 0.001-0.1, but become permissive when non-neutralizing dengue antibody is added to medium. D2V infection occurred in PBL prepared from anti-coagulated but not from defibrinated plasma. Infection enhancement was produced by multiple lots of heterotypic anti-dengue raised in several mammalian species. Homotypic anti-dengue neutralized D2V at high concentrations but enhanced at low concentrations; enhancement end point in one serum was 1:320,000. The infection-enhancing factor was a noncytophilic antibody of the IgG class. D2V infection occurred in the absence of heat-labile complement components but did not occur when complexes were prepared with anti- dengue F(ab)(2). Treatment of PBL with several proteases increased permissiveness to D2V infection by immune complexes but not by virus alone. Two rhesus monkey serums collected 14 days after D2V infection contained an IgG antibody with high-titered enhancing activity but with no hemagglutination-inhibition or neutralizing activity. Virus-antibody complexes are irreversibly attached to PBL within 15 min and completely internalized in 60 min. There was considerable variation in cellular infection in different experiments, however, maximum virus yields usually exceeded 1,000 plaque-forming units per 1 x 10(6) PBL occurring between 2 and 4 days in culture. In vitro antibody-dependent infection of PBL provides a possible model for study of pathogenetic mechanisms in infants with dengue shock syndrome who passively acquire maternal anti-dengue IgG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Isolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Techniques for Hemagglutination and Hemagglutination-Inhibition with Arthropod-Borne Viruses
Clarke, D. H., & Casals, J. (1958) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1958.7.561 · Cited by 2,045
Research on Dengue during World War II
Sabin, A. B. (1952) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1952.1.30 · Cited by 951
Nisonoff, A., Wissler, F. C., Lipman, L. N., & Woernley, D. L. (1960) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(60)90049-7 · Cited by 936
Halstead, S. B., Nimmannitya, S., & Cohen, S. N. (1970) · PubMed Central · Cited by 572
Self-citationAntibody-enhanced dengue virus infection in primate leukocytes
HALSTEAD, S. B., & O'ROURKE, E. J. (1977) · Nature · doi:10.1038/265739a0 · Cited by 550
Self-citationObservations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.
Halstead, S. B. (1970) · PubMed Central · Cited by 428
Self-citationA Plaque Reduction Test for Dengue Virus Neutralizing Antibodies
Russell, P. K., Nisalak, A., Sukhavachana, P., & Vivona, S. (1967) · The Journal of Immunology · doi:10.4049/jimmunol.99.2.285 · Cited by 425
Cited by
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Dengue: a continuing global threat
Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., et al. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2460 · Cited by 2,082
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632
Pathogenesis of dengue: challenges to molecular biology
Halstead, S. (1988) · Science · doi:10.1126/science.239.4839.476 · Cited by 1,614
Self-citationPresent and future arboviral threats
Weaver, S. C., & Reisen, W. K. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.008 · Cited by 1,566
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Viral targets for vaccines against COVID-19
Dai, L., & Gao, G. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00480-0 · Cited by 1,048
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943
Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.-M., Malasit, P., Rey, F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3515 · Cited by 914
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
Halstead, S. B. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)60011-4 · Cited by 739
Self-citationWilder-Smith, A., Ooi, E.-E., Horstick, O., & Wills, B. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32560-1 · Cited by 692
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Lee, W. S., Wheatley, A. K., Kent, S. J., & DeKosky, B. J. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00789-5 · Cited by 676
Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants
Qu, L., Yi, Z., Shen, Y., Lin, L., Chen, F., Xu, Y., Wu, Z., Tang, H., Zhang, X., Tian, F., et al. (2021) · doi:10.1101/2021.03.16.435594 · Cited by 636
“Antibody-dependent enhancement (ADE) of infection by virusspecific antibodies is another potential concern for vaccines that has been reported for infections by some viruses, including Zika, Dengue, and coronaviruses (Dowd and Pierson, 2011; Halstead and O’Rourke, 1977; Rey et al., 2018; Takano et al., 2019; Wen et al…”
Henchal, E. A., & Putnak, J. R. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.4.376 · Cited by 620
The role of IgG Fc receptors in antibody-dependent enhancement
Bournazos, S., Gupta, A., & Ravetch, J. V. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00410-0 · Cited by 617
Jessie, K., Fong, M. Y., Devi, S., Lam, S. K., & Wong, K. T. (2004) · The Journal of Infectious Diseases · doi:10.1086/383043 · Cited by 613
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Avirutnan, P., Punyadee, N., Noisakran, S., Komoltri, C., Thiemmeca, S., Auethavornanan, K., Jairungsri, A., Kanlaya, R., Tangthawornchaikul, N., Puttikhunt, C., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500949 · Cited by 509
Dengue virus life cycle: viral and host factors modulating infectivity
Rodenhuis-Zybert, I. A., Wilschut, J., & Smit, J. M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0357-z · Cited by 499
IgA and the intestinal microbiota: the importance of being specific
Pabst, O., & Slack, E. (2020) · Mucosal Immunology · doi:10.1038/s41385-019-0227-4 · Cited by 484
The Biology and Detection of Immune Complexes
Theofilopoulos, A. N., & Dixon, F. J. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60800-7 · Cited by 467
Antibody-Enhanced Infection by HIV-1 Via Fc Receptor-Mediated Entry
Takeda, A., Tuazon, C. U., & Ennis, F. A. (1988) · Science · doi:10.1126/science.2972065 · Cited by 460
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Ackerman, M. E., Moldt, B., Wyatt, R. T., Dugast, A.-S., McAndrew, E., Tsoukas, S., Jost, S., Berger, C. T., Sciaranghella, G., Liu, Q., et al. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.016 · Cited by 450
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
Roehrig, J. T., Hombach, J., & Barrett, A. D. T. (2008) · Viral Immunology · doi:10.1089/vim.2008.0007 · Cited by 450
Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges
Guzman, M. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(03)00010-6 · Cited by 446
In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody
Halstead, S. B. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.4.527 · Cited by 438
Self-citationAntibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic Cascade
Halstead, S. B. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_4.s830 · Cited by 433
Self-citationGeographic Expansion of Dengue: The Impact of International Travel
Wilder-Smith, A., & Gubler, D. J. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.07.002 · Cited by 430
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1223-1231.2005 · Cited by 429
Dengue in the Early Febrile Phase: Viremia and Antibody Responses
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Rothman, A. L., Ennis, F. A., & Nisalak, A. (1997) · The Journal of Infectious Diseases · doi:10.1086/514048 · Cited by 427
Wilder-Smith, A., & Schwartz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041927 · Cited by 423
Macrophages and control of granulomatous inflammation in tuberculosis
Flynn, J. L., Chan, J., & Lin, P. L. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.14 · Cited by 417
CLEC5A is critical for dengue-virus-induced lethal disease
Chen, S.-T., Lin, Y.-L., Huang, M.-T., Wu, M.-F., Cheng, S.-C., Lei, H.-Y., Lee, C.-K., Chiou, T.-W., Wong, C.-H., & Hsieh, S.-L. (2008) · Nature · doi:10.1038/nature07013 · Cited by 411
Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70166-3 · Cited by 409
Self-citationCurrent Understanding of the Pathogenesis of Dengue Virus Infection
Bhatt, P., Sabeena, S. P., Varma, M., & Arunkumar, G. (2021) · Current Microbiology · doi:10.1007/s00284-020-02284-w · Cited by 378
Avirutnan, P., Malasit, P., Seliger, B., Bhakdi, S., & Husmann, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6338 · Cited by 377
Green, S., Vaughn, D. W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Lew, R., Innis, B. L., Kurane, I., Rothman, A. L., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314680 · Cited by 371
Dengue Antibody-Dependent Enhancement: Knowns and Unknowns
Halstead, S. B. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0022-2014 · Cited by 336
Self-citationAntibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Takada, A., & Kawaoka, Y. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.405 · Cited by 332
OhAinle, M., Balmaseda, A., Macalalad, A. R., Tellez, Y., Zody, M. C., Saborío, S., Nuñez, A., Lennon, N. J., Birren, B. W., Gordon, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003084 · Cited by 329
Adaptive immune responses to primary and secondary dengue virus infections
St. John, A. L., & Rathore, A. P. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0123-x · Cited by 327
Tick-borne virus diseases of human interest in Europe
Charrel, R. N., Attoui, H., Butenko, A. M., Clegg, J. C., Deubel, V., Frolova, T. V., Gould, E. A., Gritsun, T. S., Heinz, F. X., Labuda, M., et al. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01022.x · Cited by 323
Antibody-Dependent Enhancement of Infection and the Pathogenesis of Viral Disease
Morens, D. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.3.500 · Cited by 317
Antibody-Dependent Enhancement of Virus Infection and Disease
Tirado, S. M. C., & Yoon, K.-J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 313
Kurane, I., Innis, B. L., Nimmannitya, S., Nisalak, A., Meager, A., Janus, J., & Ennis, F. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115457 · Cited by 312
Wang, W.-H., Urbina, A. N., Chang, M. R., Assavalapsakul, W., Lu, P.-L., Chen, Y.-H., & Wang, S.-F. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.007 · Cited by 310
Ferguson, N., Anderson, R., & Gupta, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.790 · Cited by 304
Selective Primary Health Care: Strategies for Control of Disease in the Developing World. XI. Dengue
Halstead, S. B. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.2.251 · Cited by 298
Self-citationHo, D. D., Sarngadharan, M. G., Hirsch, M. S., Schooley, R. T., Rota, T. R., Kennedy, R. C., Chanh, T. C., & Sato, V. L. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.2024-2028.1987 · Cited by 294
Whitehorn, J., & Simmons, C. P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.022 · Cited by 282
Lai, S., Huang, Z., Zhou, H., Anders, K. L., Perkins, T. A., Yin, W., Li, Y., Mu, D., Chen, Q., Zhang, Z., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0336-1 · Cited by 281
Avirutnan, P., Zhang, L., Punyadee, N., Manuyakorn, A., Puttikhunt, C., Kasinrerk, W., Malasit, P., Atkinson, J. P., & Diamond, M. S. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030183 · Cited by 274
T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?
Mongkolsapaya, J., Duangchinda, T., Dejnirattisai, W., Vasanawathana, S., Avirutnan, P., Jairungsri, A., Khemnu, N., Tangthawornchaikul, N., Chotiyarnwong, P., Sae-Jang, K., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3821 · Cited by 258
Fc receptors in antibody‐dependent enhancement of viral infections
Taylor, A., Foo, S., Bruzzone, R., Vu Dinh, L., King, N. J. C., & Mahalingam, S. (2015) · Immunological Reviews · doi:10.1111/imr.12367 · Cited by 255
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
Duangchinda, T., Dejnirattisai, W., Vasanawathana, S., Limpitikul, W., Tangthawornchaikul, N., Malasit, P., Mongkolsapaya, J., & Screaton, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010867107 · Cited by 255
Kwissa, M., Nakaya, H. I., Onlamoon, N., Wrammert, J., Villinger, F., Perng, G. C., Yoksan, S., Pattanapanyasat, K., Chokephaibulkit, K., Ahmed, R., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.06.001 · Cited by 254
Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam
Aguas, R., Dorigatti, I., Coudeville, L., Luxemburger, C., & Ferguson, N. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-45816-6 · Cited by 207
Quinlan, B. D., Mou, H., Zhang, L., Guo, Y., He, W., Ojha, A., Parcells, M. S., Luo, G., Li, W., Zhong, G., et al. (2020) · doi:10.1101/2020.04.10.036418 · Cited by 140
“ADE contributes to the pathology of other viral diseases, notably those caused by flaviviruses, and in those cases, non-neutralizing antibodies promote more efficient ADE than those which also neutralize (Dejnirattisai et al., 2010; Halstead and O'Rourke, 1977; Takada and Kawaoka, 2003).”
BackgroundThe role and function of Fcγ receptors on myeloid cells
Bournazos, S., Wang, T. T., & Ravetch, J. V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0045-2016 · Cited by 138
LaFleur, C., Granados, J., Vargas-Alarcon, G., Ruíz-Morales, J., Villarreal-Garza, C., Higuera, L., Hernández-Pacheco, G., Cutiño-Moguel, T., Rangel, H., Figueroa, R., et al. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00682-1 · Cited by 103
Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice
Zhang, M., Sun, J., Li, M., & Jin, X. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.013 · Cited by 90
Metadata
- Authors
- Halstead, S., & O'Rourke, E.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1977-07-01
- Volume
- 146
- Issue
- 1
- Pages
- 201-217
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2127896903
- Cited by
- 804
- References
- 21
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.